EuroCoord supports World AIDS Day 2014
Monday 1 December 2014 marks the 26th annual World AIDS Day which is an opportunity to show support for people living with HIV/AIDS, to remember those who have died, and to unite in the fight against HIV.
EuroCoord is key signatory of Data Protection Regulation position statement
Along with other non-commercial research organisations and academics from across Europe, EuroCoord has signed a position statement in response to proposed amendments to Articles 81 and 83 of the Data Protection Regulation adopted by the European Parliament.
18th International Workshop on HIV Observational Workshops (IWHOD)
The International Workshop on HIV Observational Databases (IWHOD), organised by EuroCoord, took place in March 2014 in Sitges, Spain and was attended by 190 delegates representing a total of 71 cohorts or collaborations.
EuroCoord Policy Brief 2013
Since AIDS was first recognised in the early 1980s, significant advances have been made in HIV management and treatment leading to considerable reductions in morbidity and mortality.
EuroCoord supports World AIDS Day
Sunday 1 December 2013 marks the 25th annual World AIDS Day which is an opportunity to show support for people living with HIV/AIDS, to remember those who have died, and to unite in the fight against HIV.
A Phylogenetics Workshop was held at Skåne University Hospital in Malmö from 24th-25th October 2013.
Higher incidence of AIDS-defining illnesses at CD4 counts of 500–749 cells/μL compared to 750–999 cells/μL
A paper published by the COHERE study in EuroCoord has found a higher incidence of AIDS-defining illnesses (ADIs) in HIV positive people with a current CD4 count of 500–749 cells/μL compared to those with a CD4 count of 750–999 cells/μL, but no further decrease at higher CD4 counts.
Current antiretroviral agents seem to have similar efficacy in subtype B and most widely encountered non-B infections in high-income countries
A study by the CASCADE Collaboration in EuroCoord reports that response to treatment was similar across groups of HIV infected individuals with different subtypes of the infecting virus.
Efforts to ensure earlier diagnosis of HIV infection across Europe are still needed
Late diagnosis of HIV infection and entry into care remains a substantial problem across Europe according to a paper published by COHERE in EuroCoord.
Study shows delayed HIV diagnosis and cART initiation, and increased mortality among individuals with less education.
The COHERE in EuroCoord study was presented during the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention and is part of the National AIDS Treatment Advocacy Project’s IAS conference report.
EuroCoord methodology meeting
As in previous years of the grant, statisticians involved in EuroCoord met to attend a training course as well as assess the state of the art for a specific methodology. This year the focus was on the analysis of both static and dynamic treatment interventions using marginal structural models.
Study shows improvements in access to antiretroviral therapy for HIV-positive pregnant women in Ukraine, but barriers remain
A study published in WHO Bulletin
today demonstrates a substantial reduction in rates of mother-to-child transmission (MTCT) of HIV following increased coverage with combination antiretroviral therapy (cART) among HIV-positive pregnant women in Ukraine.
Tr@inforPedHIV 2013 – Registration now open!
The next Tr@inforPedHIV course will be taking place in Rome 23-25 October 2013.
Recent study by the CASCADE Collaboration in EuroCoord chosen to be part of first issue of 'UNAIDS HIV This Month'
The study investigating the effect of HCV infection on HIV-associated disease progression has been selected by HIV This Month
to be part of its January 2013 issue.
Significant differences in the rate of immune system deterioration in HIV-infected individuals associated with the subtype of the infecting virus
A study by the CASCADE Collaboration in EuroCoord reports that HIV infected people have significant differences in the rate of their immune system deterioration, associated with the subtype of the infecting virus.
Study identifies patients able to maintain virological control after interruption of treatment initiated close to HIV infection
A study by the CASCADE Collaboration in EuroCoord has identified HIV positive patients who control their infection for more than 2 years after interruption of short-course antiretroviral therapy initiated close to the time of infection.
EuroCoord in association with NA-ACCORD and IeDEA will host a joint symposium entitled Global cohort collaborations and the role of extremely large datasets in HIV/AIDS and other diseases on Monday 23 July from 18.30-20.30 during the XIX International AIDS Conference in Washington DC.
16th International Workshop on HIV Observational Workshops (IWHOD)
The International Workshop on HIV Observational Databases (IWHOD
) took place in March 2012 in Athens and was attended by 190 delegates. A total of 67 cohorts or collaborations were represented at this closed meeting which is organised by EuroCoord.
Mortality rates in certain groups of HIV positive people on treatment are similar to those in the general population
A study by COHERE in EuroCoord has shown that mortality patterns in treated HIV positive people with a high CD4 count who are not injecting drug users are similar to those in the general population.
EuroCoord methodology subgroup
Accurate and appropriate statistical analyses of the data collected from participating cohorts and clinics are fundamental to the success of the ongoing research agenda in EuroCoord.
No evidence of clinical benefit for patients starting treatment with a healthy immune system
A paper published by the CASCADE Collaboration in EuroCoord has found no evidence of clinical benefit for patients starting HIV treatment at higher CD4 cell counts of between 500-799 cells/mm3.
EuroCoord supports World AIDS Day
Thursday 1 December marks the 23rd annual World AIDS Day which is an opportunity to show support for people living with HIV, to remember those who have died, and to unite in the fight against HIV.
Study shows substantial increases in the number of people requiring treatment
A study by the CASCADE Collaboration in EuroCoord has estimated that there will be a substantial increase in the number of HIV positive people who will require treatment within the first 5 years after becoming infected, following changes in treatment guidelines.
The importance of timely initiation of combination antiretroviral therapy (cART) to prevent major AIDS-defining cancers
Looking specifically at Kaposi Sarcoma (KS) and non-Hodgkin lymphoma (NHL), the authors used data on 689 cases and 4,588 controls and found that an initially low and decreasing CD4 cell count during the year prior to diagnosis was predictive of both malignancies. The association between a weak and weakening immune system and cancer risk was significant even when the analysis was restricted to the period after 2000, when cART was widely available.
EuroCoord briefing document
The aims and structure of EuroCoord are outlined in a briefing document which is now available.
Study highlights challenges of maintaining long-term viral suppression in children
An MRC-funded study supported by EuroCoord published in the Lancet, has shown that 12% of children with HIV develop triple class virological failure by 5 years after starting antiretroviral therapy (ART), and 20% by 8 years.
Tr@inforPedHIV 2011 – Registration now open!
The next Tr@inforPedHIV course will be taking place in Rome 24-26 October 2011.
First publication from EuroCoord-CHAIN project
Data from EuroCoord were used in an analysis which investigated the effect of Transmitted Drug Resistance (TDR) on outcome in the first year of combination antiretroviral therapy (cART).
Welcome to the new EuroCoord website
We hope you find the new website useful and easy to navigate.